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Abstract
Background: Enchondromas and atypical cartilaginous tumors (ACT) are often located at the proximal humerus.
Most lesions can be followed conservatively, but surgical resection may alleviate pain, avoid pathological fractures,
and prevent transformation into higher grade chondrosarcomas. Rigorous intralesional resection and filling with
polymethylmethacrylate bone cement has been proposed for enchondromas but also for ACT, as an alternative for
extralesional resection. We intended to analyze radiological, clinical, and functional outcome of this strategy and
compare bone cement without osteosynthesis to bone cement compound osteosynthesis, which has not been
analyzed so far.
Methods: We retrospectively analyzed 42 consecutive patients (mean follow-up 73 months; range 8–224) after
curettage and bone cement filling with or without osteosynthesis. Exclusion criteria were Ollier’s disease and
cancellous bone filling. Twenty-five patients only received bone cement. Seventeen patients received additional
proximal humerus plate for compound osteosynthesis to increase stability after curettage. Demographics and
radiological and clinical outcome were analyzed including surgery time, blood loss, hospitalization, recurrences, and
complications. An additional telephone interview at the final follow-up assessed postoperative satisfaction, pain,
and function in the quick disabilities of the arm, shoulder, and hand (DASH) score and the Musculoskeletal Tumor
Society (MSTS) score. Statistics included the Student T tests, Mann-Whitney U tests, and chi-square tests.
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Results: No osteosynthesis compared to compound osteosynthesis showed smaller tumors (4.2 (± 1.5) cm versus
6.6 (± 3.0) cm; p = 0.005) and smaller bone cement fillings after curettage (5.7 (± 2.1) cm versus 9.6 (± 3.2) cm;
p = 0.0001). A score evaluating preoperative scalloping and soft-tissue extension did not significantly differ (1.9 (± 0.9)
versus 2.0 (± 1.0); rating scale 0–4; p = 0.7). Both groups showed high satisfaction (9.2 (± 1.5) versus 9.2 (± 0.9); p = 0.5)
and low pain (1.0(±1.7) versus 1.9(±1.8); p = 0.1) in a rating scale from 0 to 10. Clinical and functional outcome was
excellent for both groups in the DASH score (6.0 (± 11.8) versus 11.0 (± 13.2); rating scale 0–100; p = 0.2) and the MSTS
score (29.0 (± 1.7) versus 28.7 (± 1.1); rating scale 0–30; p = 0.3). One enchondroma recurrence was found in the group
without osteosynthesis. Complications (one fracture and one intra-articular screw) were only detected after osteosynthesis.
Osteosynthesis had longer surgery time (70 (± 21) min versus 127 (± 22) min; p < 0.0001), more blood loss
(220 (± 130) ml versus 460 (± 210) ml; p< 0.0001), and longer stay in the hospital (6 (± 2) days versus 8 (± 2) days; p= 0.004).
Conclusions: Intralesional tumor resection was oncologically safe and clinically successful with or without osteosynthesis.
Osteosynthesis did not reduce the risk for fracture but was more invasive.
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Background
Chondrogenic tumors such as enchondromas and atyp-
ical cartilaginous tumors (ACT = chondrosarcoma grade
I according to older nomenclature) are often located at
the proximal humerus [1] and raise the question for sur-
gical therapy. Enchondromas at the shoulder are often
found incidentally on radiographs or after imaging due
to unspecific pain but differentiation between more fre-
quently found enchondromas and rather rarely found
ACT only by pain seems impossible [1, 2]. Clinical,
radiological, and even histological differentiation be-
tween enchondromas and the more aggressive low-grade
malignant ACT is extremely challenging [3–5]. In case
of clinically inactive lesions, conservative treatment
with clinical and radiological follow-up seems
sufficient [6]. In case of clinical and radiological ag-
gressiveness with endosteal scalloping, soft-tissue ex-
tension, lesion growth or size > 6 cm, and pain not
related to other shoulder co-morbidities, most authors
prefer surgical treatment [1, 7–9]. Intralesional resec-
tion is well accepted for benign enchondromas where
less aggressive lesions may also be filled biologically
with cancellous bone [10] whereas bone cement filling
has the advantage of reduced recurrence rates due to
heat destruction of potentially remaining tumor cells,
which may be beneficial for large and radiologically
aggressive enchondromas, where differentiation from
ACT is difficult [1, 9, 11]. The gold standard treat-
ment for ACT with highest oncological safety is
extralesional resection [12, 13], but recent studies re-
port sufficient oncological safety and significantly bet-
ter clinical and functional results after intralesional
curettage of ACT located in the long bones [1, 7–9,
11, 14–21]. Intralesional therapy, however, seems not
appropriate for ACT of the pelvis and trunk as well
as for cases with local recurrence of ACT indicating a
more aggressive phenotype [22].
Due to lack of evidence in the literature, we intended
to retrospectively analyze our large series of 42 consecu-
tive patients with enchondroma or ACT of the proximal
humerus surgically treated with rigorous intralesional
excision and bone cement filling either with additional
proximal locking compression plate (LCP) humerus
plate or without a plate. Whether additional osteosynth-
esis as a bone cement compound osteosynthesis [23–25]
is beneficial at the proximal humerus has not been ana-
lyzed so far, so we compared both groups regarding the
following research questions: Is clinical and functional
outcome different? Is radiologic appearance of the le-
sions different? Is there a difference in recurrences, com-
plications, or other surgical parameter?
Methods
We retrospectively analyzed 42 consecutive patients surgi-
cally treated for enchondroma or ACT at the proximal hu-
merus with a mean follow-up of 73 months (range 8–224).
Approval was given by our local ethical committee.
From 2005 till 2017, we found a total of 113 patients
treated conservatively or surgically at our orthopedic
oncology outpatient clinic (level I bone and soft-tissue
tumor center and orthopedic and trauma surgery uni-
versity hospital). Exclusion criteria were no surgical
therapy (n = 65), less than 6 months follow-up (n = 1),
Ollier’s disease (n = 1), and filling with cancellous bone
(n = 4) instead of bone cement, as cancellous bone fill-
ing was only used for smaller and less aggressive
enchondromas and hence could not be compared.
Forty-two patients with sufficient data which were sur-
gically treated between 2006 and 2016 were finally in-
cluded in the study (Fig. 1). Of those, 25 patients
underwent rigorous intralesional excision with use of a
high-speed burr and filling of the lesion with polymethyl-
methacrylate bone cement (Palacos® R+G; Heraeus
Medical, Hanau, Germany) to achieve improved
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stability and reduce recurrence rate due to heat de-
struction of potentially remaining tumor cells during
the polymerization process in the lesion cave (Figs. 2
and 3). This group was defined as the study group.
Seventeen other patients underwent the same proced-
ure followed by the support of a proximal humerus
locking compression plate (LCP; PHILOS plate,
Synthes GmbH, Oberdorf, Switzerland) in a way that
the screws of the osteosynthesis were integrated into
the bone cement as a compound plate osteosynthesis
(Figs. 4 and 5). This group was defined as the control
group.
A decision whether additional compound plate
osteosynthesis with a proximal humerus plate was
used or not was done individually. According to the
documented medical records, additional plate osteo-
synthesis was justified and selected, if preoperative
imaging and intraoperative appearance after curettage
caused doubt of sufficient stability only with bone
cement. As there are no scientific guidelines for
Fig. 1 Flowchart of inclusion criteria
Fig. 2 Painful large chondrogenic tumor at the proximal humerus prior to surgery without osteosynthesis. Plain radiograph (a) shows typical
popcorn-like calcifications (arrow) inside the epiphyseal and metaphyseal lesion. STIR MRI sagittal series (b) and T1-weighted contrast-enhanced
axial MRI series (c) reveal large size and aggressiveness with endosteal scalloping (arrow) reducing stability of the proximal humerus
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decision-making, we retrospectively analyzed the po-
tential criteria.
Adopted from other studies [1], lesion size was mea-
sured by the maximal diameter in MRI, as heteroge-
neous geometrical configurations of the lesions hamper
valid measurement of lesion volumes. Preoperative le-
sion size and postoperative size of the cavity filled with
bone cement after curettage were evaluated. Preopera-
tive aggressiveness of the lesion was judged by a
semi-quantitative score considering soft-tissue extension
(no = 0, yes = 1) and endosteal scalloping (no = 0,
minimal = 1, moderate = 2, high = 3) resulting in a score
from 0 to 4. Scalloping was considered minimal if it
involved less than one third of the cortical thickness,
moderate if it involved up to two thirds, and high if it in-
volved more than two thirds. Radiological evaluation
with x-rays and MRIs was performed initially and regu-
larly with intervals between 6 (first year after surgery)
and 12 months for clinical routine. Imaging was evalu-
ated together with our musculoskeletal radiologists sub-
specialized in bone and soft-tissue tumor diagnostic.
Patient demographics (Table 1) and clinical histories
including detailed information on surgical treatment,
histological analysis, recurrences, and complications
were analyzed. For systematic evaluation of pain, patient
satisfaction, and functional outcome at final follow-up,
Fig. 3 Bone cement filling without osteosynthesis after rigorous intralesional tumor resection. The large bone cement filling (arrow) can be easily
depicted in plain radiographs (a) and MRI with T2-weighted sagittal series (b) and T1-weighted contrast-enhanced axial series (c). Although filling
out the complete proximal humerus, sufficient stability was achieved without additional osteosynthesis as no postoperative fractures were found
later on for all equally treated cases. Typical edema line (arrow in c) after bone cement implantation must be distinguished from local recurrence
Fig. 4 Painful large chondrogenic tumor at the proximal humerus prior to surgery with additional osteosynthesis. Plain radiograph (a) with typical
popcorn-like calcifications (arrow) and T1-weighted axial MRI series (b) and T1-weighted contrast-enhanced coronal series (c) with endosteal
scalloping (arrows) and reduced stability without significant differences compared to lesions treated without osteosynthesis (compare Fig. 1)
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we performed an additional telephone interview.
Remaining pain and overall patient satisfaction were
asked to be judged from 0 to 10. Limitations and clinical
function were evaluated by the Musculoskeletal Tumor
Society (MSTS) score [26] and the quick disabilities of
the arm, shoulder, and hand (DASH) score [27].
To evaluate the results, statistical analysis was per-
formed for the outcome measures “MSTS score”, “DASH
score”, “preoperative lesion size”, “scalloping and soft-tis-
sue extension score”, “size of bone filling”, “number of re-
currences”, “number of complications”, “blood loss”,
“surgery time”, and “days of hospitalization”. To compare
the differences, Student T tests, Mann-Whitney U tests,
and chi-square tests were calculated depending on the
scale level and distribution of the data. Statistical signifi-
cance was assumed at a p value < 0.05. Due to the explora-
tory character of the study, all p values are interpreted
descriptively. Analysis was performed together with the
statistician of our department (SG) using SPSS for
Windows 22.0 (SPSS Inc., USA).
Results
All 42 patients were followed until the final follow-up
with information on surgeries, radiological outcome,
clinical presentation in the outpatient clinic, recurrences,
and complications. Results from the telephone interview
were only available for n = 31 patients.
Surgical parameter
The group without additional osteosynthesis showed less
surgery time, less intraoperative blood loss, and less days
of hospitalization (Table 2).
Fig. 5 Bone cement filling with additional compound plate osteosynthesis after rigorous intralesional tumor resection. Plain radiographs in ap (a)
and axial (b) view show additional stabilization with a proximal locking compression plate of the humerus with integration of the screws inside
the bone cement (arrow) to potentially increase stability of the proximal humerus
Table 1 Demographics of both treatment groups
Intralesional resection
+ bone cement (n = 25)
Intralesional resection + bone cement
+ proximal humerus plate (n = 17)
Statistical test with p value
Gender
Male n = 4 n = 8 Chi-square test
p = 0.03
Female n = 21 n = 9
Age
Mean (± SD) 50.3 (± 10.8) years 48.2 (± 12.0) years Mann-Whitney U test
p = 0.52
Histology
Enchondroma n = 19 n = 12 Chi-square test
p = 0.67
ACT n = 3 n = 2
Enchondroma or ACT n = 3 n = 3
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Radiological outcome
Lesions which did not receive additional osteosynthesis
were smaller (4.2 (± 1.5) cm versus 6.6 (± 3.0) cm; p =
0.005). After curettage, the lesion cavity which was filled
with bone cement was also smaller in the group without
osteosynthesis (5.7 (± 2.1) cm versus 9.6 (± 3.2) cm; p =
0.0001). Endosteal scalloping in the group without osteo-
synthesis was minimal in 10 cases, moderate in 10 cases,
and high in 5 cases. In the group with osteosynthesis, it
was minimal in five cases, moderate in seven cases, and
high in four cases. Soft-tissue extension was only found
in four cases (two in each group). A semi-quantitative
score of preoperative scalloping and soft-tissue extension
did not show significant differences between the groups
(1.9 (± 0.9) versus 2.0 (± 1.0); rating scale 0–4; p = 0.7).
Detailed results depending on histological diagnosis are
presented in Table 3.
Clinical outcome
Overall clinical outcome was excellent. Patient satisfac-
tion, pain, and functional outcome did not show statisti-
cally significant differences. Detailed results are
presented in Table 4.
Recurrences
No recurrence was found in the osteosynthesis group.
One of the 25 patients from the group without osteo-
synthesis had a histologically proven enchondroma re-
currence after 4 years. It was successfully treated by
revision surgery, again without osteosynthesis.
Table 2 Surgical parameter
Intralesional resection
+ bone cement (n = 25)
Intralesional resection + bone cement
+ proximal humerus plate (n = 17)
Statistical test with p value
Surgery time
Mean (± SD) 70 (± 21) min 127 (± 22) min Mann-Whitney U test
p < 0.0001
Blood loss
Mean (± SD) 220 (± 130) ml 460 (± 210) ml Mann-Whitney U test
p < 0.0001
Days of hospitalization
Mean (± SD) 6 (± 2) days 8 (± 2) days Mann-Whitney U test
p = 0.004
Table 3 Radiological outcome
Intralesional resection
+ bone cement (n = 25)
Intralesional resection + bone cement
+ proximal humerus plate (n = 17)
Statistical test with p value
Initial tumor size
Mean (± SD) Student T test
All 4.2 (± 1.5) cm 6.6 (± 3.0) cm p = 0.005
Enchondroma 4.2 (± 1.7) cm 7.6 (± 3.0) cm p = 0.003
ACT 3.7 (± 1.2) cm 5.3 (± 1.1) cm p = 0.24
Enchondroma or ACT 4.3 (± 0.6) cm 4.5 (± 2.9) cm p = 0.26
Cavity size after curettage
Mean (± SD) Student T test
All 5.7 (± 2.1) cm 9.6 (± 3.2) cm p = 0.0001
Enchondroma 5.7 (± 2.2) cm 10.2 (± 2.5) cm p < 0.0001
ACT 4.7 (± 1.1) cm 5.6 (± 0.4) cm p = 0.44
Enchondroma or ACT 6.9 (± 0.3) cm 9.0 (± 4.6) cm p = 0.65
Scalloping + soft-tissue extension score
Mean (± SD)
rating scale 0–4
Mann-Whitney U test
All 1.9 (± 0.9) 2.0 (± 1.0) p = 0.71
Enchondroma 1.8 (± 1.0) 1.8 (± 0.9) p = 0.81
ACT 2.3 (± 0.6) 3.0 (± 1.4) p = 0.52
Enchondroma or ACT 2.0 (± 1.0) 2.0 (± 1.0) p = 1.0
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Difference in recurrence was not significant (chi-square
test p = 0.4).
Complications
No complications were found in the group without osteo-
synthesis. In the osteosynthesis group, two of the 17 pa-
tients had complications. This difference did not reach
statistical significance but showed a trend (chi-square test
p = 0.08). As complications, we found one peri-implant
fracture which was, however, related to a fall with ad-
equate trauma. It was treated by re-osteosynthesis with a
longer plate. Another patient needed revision surgery due
to a postoperatively found intra-articular screw.
Discussion
Intralesional resection with vigorous curettage and filling
the cavity with bone cement have been described in sev-
eral studies to treat enchondromas and low-grade malig-
nant ACT resulting in sufficient oncological safety and
excellent function [1, 7–9, 11, 14–21]. Stability after curet-
tage is an important issue, as postoperative fractures are
frequently described [10, 13, 17–19]. Biomechanically de-
manding locations such as the femur are at highest risk
[10, 19], but fractures also occur in the upper extremity
including the proximal humerus [13, 18, 23]. Bone cement
compound osteosynthesis may increase stability [23, 24],
but it remains unclear whether this approach is beneficial
at the proximal humerus or not [25]. Advantages and dis-
advantages have not been analyzed so far, so we for the
first time compared intralesional tumor resection and
bone cement filling with and without additional plate
osteosynthesis at the proximal humerus.
Preoperative tumor size and size of the tumor cavity
after curettage were significantly different with smaller
lesions in patients without osteosynthesis and larger le-
sions in patients with additional osteosynthesis. Hence,
surgeons will have to judge larger lesions to be at higher
risk for instability or postoperative fracture and therefore
decide to implant additional osteosynthesis more often
in these cases. All lesions were radiologically judged as
aggressive, without significant difference of the groups
in the scalloping and soft-tissue extension score. Conse-
quently, size will have predominantly influenced the de-
cision towards osteosynthesis. Besides generally high
radiologic aggressiveness of the lesions of the present
series, only 11 lesions were histologically diagnosed as
ACT or potential ACT compared to the majority of his-
tologically benign diagnosed enchondromas. Valid differ-
entiation between ACT and aggressive enchondromas by
histology might be questionable. This is supported by
several other studies, documenting difficult or even im-
possible differentiation of both entities [1, 3–5].
In case of additional osteosynthesis, surgery time was
significantly longer with significantly more blood loss
and longer hospital stay afterwards. Hence, it would be
beneficial to avoid additional osteosynthesis. Significant
clinical and functional differences regarding MSTS
score, DASH score, pain, and satisfaction were not found
after intralesional resection with or without osteosynth-
esis. Both treatment groups had excellent clinical out-
come with high satisfaction, low pain, and only minimal
functional impairments. Compared to other studies on
intralesional resection strategy, our MSTS score results
were similar and even slightly better [1, 9, 11, 13, 16].
As reported by others, this strategy not only maintains
excellent function but also offers sufficient oncological
safety [1, 7–9, 11, 14–21]. In our series, no ACT recur-
rence but one enchondroma recurrence was found
4 years after intralesional tumor resection with bone ce-
ment filling without osteosynthesis. Patients with add-
itional osteosynthesis did not show recurrence. Higher
recurrence rate in cases without additional osteosynth-
esis might theoretically be explained by less radical
tumor resection, as the surgeon might have been afraid
Table 4 Clinical and functional outcome
Intralesional resection
+ bone cement (n = 19)
Intralesional resection + bone cement
+ proximal humerus plate (n = 12)
Statistical test with p value
Satisfaction
Mean (± SD)
rating scale 0–10
9.2 (± 1.5) 9.2 (± 0.9) Mann-Whitney U test
p = 0.5
Pain
Mean (± SD)
rating scale 0–10
1.0 (± 1.7) 1.9 (± 1.8) Mann-Whitney U test
p = 0.1
DASH score
Mean (± SD)
rating scale 0–100
6.0 (± 11.8) 11.0 (± 13.2) Mann-Whitney U test
p = 0.2
MSTS score
Mean (± SD)
rating scale 0–30
29.0 (± 1.7) 28.7 (± 1.1) Mann-Whitney U test
p = 0.3
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of instability. Difference in recurrence was not signifi-
cant but valid comparison is not possible due to only
one found recurrence. As a disadvantage of additional
osteosynthesis, postoperative MRI images showed higher
artifacts although the plates are made of titanium. This
problem, however, can be sufficiently solved with the lat-
est MRI technology using artifact suppressing algorithms
[28], so local tumor recurrences can still be ruled out
with sufficient reliability. We did not find pulmonary
metastases until the final follow-up. ACT as a grade I
malignancy and even enchondromas offer potential risk
for transformation into higher grade chondrosarcomas
which has been reported with percentages from 1 to 9%
[5, 6, 29]. The highest risk is known for tumors of the
axial skeleton, pelvis, and truck; hence, intralesional
therapy seems less appropriate in these cases [1, 12, 13,
30]. In case of ACT recurrence, a more aggressive
phenotype is expected with higher risk for transform-
ation into higher grade chondrosarcoma, so most au-
thors recommend wide resection in such cases [22, 30].
The lowest risk is expected for ACT of the long bones
of the appendicular skeleton without statistical evidence
for differences between the upper and lower extremity
[30]. Nevertheless, the literature more often reports on
recurrences at the femur and tibia [1, 13, 20] compared
to the humerus [11]. In the series of Andreou et al. in-
cluding 225 patients with ACT, 46 lesions were in the
upper extremity but no transformation into higher grade
chondrosarcoma or pulmonary metastases were found
contrary to 5 transformations into grade II chondrosar-
coma with additional pulmonary metastases in ACT lo-
cated in the femur and tibia. Analysis of metastasis-free
survival, however, was not significantly different al-
though the overall number of analyzed cases was very
high in this multicenter study [30].
We had two complications, and they were only found
after additional osteosynthesis. The intra-articular screw
can be directly related to the procedure. The postopera-
tive fracture had an adequate trauma and hence cannot
be clearly attributed to the osteosynthesis. In case of
additional osteosynthesis, superior stability would be ex-
pected, but our data cannot prove this. No fractures
were found after intralesional excision without additional
osteosynthesis, but one fracture was found although
osteosynthesis was added. This can be interpreted differ-
ently. First, the theoretical stability increase of additional
osteosynthesis might be overestimated. Second, surgeons
might have used additional osteosynthesis more often
than needed, to achieve the highest safety. The literature
does not give sufficient answers on whether additional
osteosynthesis should be used or not. A series including
10 humerus cases treated with intralesional resection
and bone cement filling without osteosynthesis reported
no fractures [9]. Dierselhuis et al. found 11 fractures in
108 cases but there were only 33 humerus cases, of
those 2 had fractures, and detailed information on prior
osteosynthesis is not given [18]. Kim et al. analyzed 36
cases and found 4 fractures only located at the femur
whereas no fracture was found for the 23 humerus le-
sions although additional osteosynthesis was not used
[19]. In our series, the largest cavity treated without osteo-
synthesis was 12.4 cm compared to 15.2 cm for the largest
cavity in the osteosynthesis group. As we did not find frac-
tures in the group without osteosynthesis, we can only
conclude that our mean cavity size of 5.7 (± 2.1) cm was
in a safe zone at the proximal humerus and that even lar-
ger sizes up to 12.4 cm did not show problems without
osteosynthesis. For better interpretation, higher patient
numbers would be beneficial and further biomechanical
cadaver studies should be performed to achieve objective
data considering primary stability of bone cement fillings
with and without additional osteosynthesis at the proximal
humerus. So far, no data is available in the literature.
Conservative follow-up without surgery might be an
important alternative [6], although psychological and so-
cioeconomic aspects of leaving an aggressive tumor in-
side the body with need for long-time radiologic
follow-up have to be considered [31]. Conservative strat-
egy is not further discussed here, as the goal of the
present study was comparison of two surgical strategies.
Several limitations have to be mentioned. Due to the
retrospective study design, pain and function were not
systematically evaluated preoperatively, so postoperative
clinical success could not be compared to the preoperative
situation. Furthermore, decision for or against additional
osteosynthesis was done individually without a standard-
ized decision protocol with a potential selection bias.
Conclusion
Our series documents oncologically safe and clinically
successful outcome no matter if intralesional tumor re-
section was performed with bone cement filling alone or
with additional osteosynthesis at the proximal humerus.
Compound plate osteosynthesis with the intention to in-
crease stability did not reveal significant clinical disad-
vantages besides longer surgery time, more blood loss,
and longer hospitalization. Further biomechanical evalu-
ations and randomized studies should be initiated.
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